Application of lauromacrogol injection in preparation of medicine for treating spontaneous pneumothorax

Abstract

The invention relates to application of lauromacrogol injection in preparation of a medicine for treating spontaneous pneumothorax, and solves the problem that special groups cannot tolerate operations and general anesthesia in the prior art. According to the invention, the lauromacrogol injection with low recurrence rate is used as the drug for treating spontaneous pneumothorax by replacing operative treatment with drug treatment. A formula of the lauromacrogol injection comprises 1g of lauromacrogol, 5ml of ethanol (96%) and the balance of water for injection, wherein the total volume is 100ml. According to the pleural cavity adhesive, operation treatment is replaced by medicine treatment, after the lauromacrogol injection is injected into the pleural cavity, the pleura is stimulated to generate aseptic inflammation, coagulation, sclerosis, adhesion and closure, the painful reaction of the pleural cavity is not caused, and the pleural cavity adhesive is an ideal pleural cavity adhesive.

Description

Technical field: [0001] The invention belongs to the technical field of medicine application, and relates to the application of lauromacrogol injection in the preparation of medicine for treating spontaneous pneumothorax. Background technique: [0002] Spontaneous pneumothorax is caused by lung or pleural lesions, causing the visceral pleura to rupture, and the gas in the lungs overflows into the pleural cavity through the breach to separate the visceral and parietal pleura, gas accumulates between the two layers of pleura, and the lung tissue collapses. If the gas continues to overflow into the pleural cavity from the breach, tension pneumothorax will be formed, which must be dealt with immediately and effectively, otherwise it will be fatal. [0003] Pneumothorax is a common emergency in the Department of Respiratory Medicine, and it occurs frequently in winter. The usual treatment method is closed drainage, and surgical closure is used for the breach that cannot be closed...

AI Technical Summary

Problems solved by technology

[0005] The object of the present invention is to provide a kind of application of lauromacrogol injection in the preparation of the medicine for treating spontaneous pneumothorax, which overcomes the existing in the prior art that some elderly patients and patients with many underlying diseases cannot tolerate surgery and general anesthesia problem, the present invention utilizes drug therapy to replace surgical treatment, and has lower recurrence rate lauromacrogol injection as the application of medicine for the treatment of spontaneous pneumothorax

Images